Results 201 to 210 of about 202,243 (244)
Epidemiology of gastroenteropancreatic neuroendocrine tumours [PDF]
Bailliere's Best Practice and Research in Clinical Gastroenterology, 2012 Gastroenteropancreatic neuroendocrine tumours are a heterogeneous group of tumours arising from diffuse endocrine cells, causing unique clinical syndromes.
Merav Fraenkel, Antongiulio Faggiano
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biochemistry of neuroendocrine tumours
Best Practice & Research Clinical Endocrinology & Metabolism, 2007Several circulating or urinary tumour markers can be used for the diagnosis and follow-up of functioning and clinically non-functioning neuroendocrine tumours of the pancreatic islet cells and intestinal tract. Among the specific tumour markers are serotonin and its metabolites--e.g.
openaire +3 more sources
Epidemiology of Neuroendocrine Tumours
Neuroendocrinology, 2004Neuroendocrine tumours account for only 0.5% of all malignancies. The incidence is approximately 2/100,000 with a female preponderance under the age of 50 years due to appendiceal location. The main primary sites are the gastrointestinal tract (62–67%) and the lung (22–27%). Presentation with metastatic disease accounts for 12–22%. In the last decades,
B G, Taal, O, Visser
openaire +2 more sources
Pancreatic Neuroendocrine Tumours
2018Neuroendocrine tumours (NETs) are rare neoplasms; however, the incidence of NETs has increased in the last decades. Pancreatic NETs (PanNETs) and small intestinal NETs represent the majority of NETs. NETs are usually associated with a good prognosis, and the surgical resection is needed in case of lesion exceeding 2 cm or in case of functioning tumours.
Tamburrino D., Partelli S., Falconi M.
openaire +2 more sources
Management of Neuroendocrine Tumours
Clinical Oncology, 1999Neuroendocrine tumours (NET) represent a collection of anatomically diverse tumour types derived from common cell lines and unified by the secretion of neuropeptides, whose excess secretion may give rise to distinctive clinical syndromes. They arise from diffuse neuroendocrine cells found in the brain and the pituitary gland, and in sympathetic nervous
openaire +2 more sources
Apoptosis in neuroendocrine tumours
Clinical Endocrinology, 1999Acquired resistance to apoptosis in neuroendocrine tumours (NETs) may promote clonal expansion and enhance the likelihood that subsequent mutations lead to growth or persistence of the neoplastic clone. Recent studies have demonstrated that deregulation of programmed cell death may be a critical component in multistep tumourigenesis of NETs and that ...
openaire +2 more sources
Endocrine-related cancer, 2004
Abstract Neuroendocrine tumours are a heterogeneous group including, for example, carcinoid, gastroenteropancreatic neuroendocrine tumours, pituitary tumours, medullary carcinoma of the thyroid and phaeochromocytomas. They have attracted much attention in recent years, both because they are relatively easy to palliate and because they
M T, Barakat, K, Meeran, S R, Bloom
openaire +2 more sources
Abstract Neuroendocrine tumours are a heterogeneous group including, for example, carcinoid, gastroenteropancreatic neuroendocrine tumours, pituitary tumours, medullary carcinoma of the thyroid and phaeochromocytomas. They have attracted much attention in recent years, both because they are relatively easy to palliate and because they
M T, Barakat, K, Meeran, S R, Bloom
openaire +2 more sources
Tumour Biology of Gastroenteropancreatic Neuroendocrine Tumours
Neuroendocrinology, 2004Neuroendocrine tumours of the gastroenteropancreatic tract (GEP NETs) represent a rare and heterogeneous group of tumours. Based on their ontogenetic origin, GEP NETs are classified into foregut, midgut and hindgut tumours. Although they have many features in common, their molecular backgrounds are obviously different.
openaire +2 more sources
Classification of neuroendocrine tumours.
Italian journal of gastroenterology and hepatology, 1999This article focuses on the classification of neuroendocine tumours with particular emphasis on pancreatic and gastrointestinal neoplasms.
KLOPPEL G +3 more
openaire +2 more sources
Neuroendocrine tumour of the gallbladder
Gastroenterología y Hepatología (English Edition), 2020Joana Aylhin, López Marcano +4 more
openaire +2 more sources